DAVITA INC. Finance Lease, Right-of-Use Asset, Amortization
DAVITA INC. (DVA) reported Finance Lease, Right-of-Use Asset, Amortization of $26.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-02-11
- DAVITA INC. finance lease, right-of-use asset, amortization for the quarter ending 2020-03-31 was $6.08M, a 4.31% increase year-over-year.
- DAVITA INC. finance lease, right-of-use asset, amortization for the quarter ending 2019-12-31 was $6.03M.
- DAVITA INC. finance lease, right-of-use asset, amortization for the quarter ending 2019-09-30 was $6.16M.
- DAVITA INC. finance lease, right-of-use asset, amortization for the quarter ending 2019-06-30 was $5.70M.
- DAVITA INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $26.60M, a 5.89% decline from fiscal 2024.
- DAVITA INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $28.26M, a 4.81% increase from fiscal 2023.
- DAVITA INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $26.96M, a 0.42% decline from fiscal 2022.
- DAVITA INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $27.08M, a 0.87% increase from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $26.60M 10-K · filed 2026-02-11 | |||
| 2024-12-31 | $28.26M 10-K · filed 2026-02-11 | |||
| 2023-12-31 | $26.96M 10-K · filed 2026-02-11 | |||
| 2022-12-31 | $27.08M 10-K · filed 2025-02-13 | |||
| 2021-12-31 | $26.85M 10-K · filed 2024-02-14 | |||
| 2020-12-31 | $24.72M 10-K · filed 2023-02-22 | |||
| 2020-03-31 | $6.08M 10-Q · filed 2020-05-05 | $12.11M derived: sum of 2 quarters · filed 2022-02-11 | $18.27M derived: sum of 3 quarters · filed 2022-02-11 | $23.98M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $12.20M derived: sum of 2 quarters · filed 2022-02-11 | $17.90M derived: sum of 3 quarters · filed 2022-02-11 | $23.72M 10-K · filed 2022-02-11 |
| 2019-09-30 | $6.16M 10-Q · filed 2019-11-07 | $11.87M derived: sum of 2 quarters · filed 2019-11-07 | $17.69M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $5.70M 10-Q · filed 2019-08-02 | $11.53M 10-Q · filed 2019-08-02 | ||
| 2019-03-31 | $5.83M 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |